Maryland 2025 Regular Session

Maryland Senate Bill SB519

Introduced
1/24/25  

Caption

Prostate Cancer Care Access Grant Program and Fund - Establishment

Summary

SB 519 establishes the Prostate Cancer Care Access Grant Program within the Maryland Department of Health to improve awareness of and access to prostate cancer care services for people in the state. The bill authorizes the Secretary of Health to award grants to entities and prostate cancer care providers for public education and outreach, to help cover travel and related costs for individuals who cannot access care in their own communities, and for other initiatives that improve access to culturally competent prostate cancer care. The bill also creates the Prostate Cancer Care Access Grant Program Fund as a special, nonlapsing fund to support the program. The fund may receive state appropriations, interest earnings, and other accepted money, and the Secretary administers it. The bill directs that interest earned on the fund be credited back to the fund rather than the General Fund, and it requires a minimum $100,000 allocation for fiscal year 2026 and a $100,000 appropriation in each of fiscal years 2027 and 2028.

Impact

SB 519 adds a new subtitle to the Health-General Article establishing a new grant program and fund, and it amends State Finance and Procurement law to exempt the new fund from the general rule that interest on certain state money accrues to the General Fund. In practical terms, it creates a dedicated funding stream for prostate cancer outreach and access initiatives and requires the Governor to budget specified amounts for the program over multiple fiscal years. The bill affects the Department of Health, grant recipients, prostate cancer care providers, and individuals facing barriers to diagnosis or treatment, especially those needing travel assistance or culturally competent services.

Sentiment

Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears supportive and public-health oriented. The measure is framed as a targeted access and awareness initiative rather than a controversial regulatory change, and its structure suggests an effort to address disparities in prostate cancer care. No opposition or divided vote is reflected in the available record.

Contention

The main potential point of contention is fiscal: the bill creates a dedicated fund and requires minimum appropriations, which commits state resources over several years. Another possible issue is policy design, including how grants will be awarded, what qualifies as culturally competent care, and how the Secretary will determine which initiatives receive funding. However, no specific objections, amendments, or competing viewpoints are included in the provided committee or voting history.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.